COM:ALTIMMUNE
Altimmune, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalwebsite
altimmune.com/crunchbase
vaxin-inclinkedin
altimmuneipo date
May 26, 2017
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcel...Show More